Pathology

Julie Tetzlaff, PhD

Assistant Professor of Pathology

Dr. Tetzlaff is the scientific coordinator of the Wisconsin SIDS Center interest group. In addition, she coordinates projects, grants and research within the Pathology Department.

Research Interests

• Sudden Infant Death Syndrome
• Vascular Anomalies
• Neuroscience
• Environmental and Occupational Health studies in Peru

Professional Background

• Scientist, Seaside Therapeutics, Cambridge, MA (2008-2011)
• Assistant Professor, Department of Pathology, Medical College of Wisconsin (2011-Present)

Educational Background

• BA, University of Wisconsin-Milwaukee
• PhD, Loyola University Chicago, Maywood, IL
• Postdoc, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Selected Publications

• Outeiro TF, Klucken J, Bercury K, Tetzlaff JE, Putcha, P, McLean PJ, and Hyman BT (2009). Dopamine-induced conformational changes in α-synuclein. PLoS ONE, 4(9):e6906.
• Tetzlaff JE, Outeiro, TF, Putcha P, Ivanov A, Hyman BT and McLean PJ (2008). CHIP targets toxic α-synuclein oligomers for degradation. JBC, 283(26):17962-8.
• Outeiro, TF, Putcha P, Tetzlaff JE, Spoelgen, R, Koker M, Carvalho F, Hyman BH and McLean PJ (2008). Formation of toxic oligomeric α-synuclein species in living cells. PLoS ONE, 3(4):e1867.
• Outeiro, TF and Tetzlaff JE (2007). Mechanisms of Disease II-Cellular Protein Quality Control (2007). Seminars in Neurology, 14(1):15-25.
• Tetzlaff JE, Tanzer L and Jones KJ (2007a). Cellular Localization of Androgen and Estrogen Receptors in Mouse-Derived Motoneuron Hybrid Cells and Mouse Facial Motoneurons. Journal of Neurobiology, 67(10):1362-1370.
• Tetzlaff JE, Tanzer L and Jones KJ. Exogenous Androgen Treatment Delays the Stress Response Following Hamster Facial Nerve Injury (2007b). Journal of Neuroendocrinology, 19(5):383-9.
• Tetzlaff JE, Huppenbauer C, Tanzer L, Alexander T, Jones K (2006). Motoneuron injury and repair: new perspectives on gonadal steroid hormones as neurotherapeutics. Journal of Molecular Neuroscience, 28(1):53-64.
• Chen Z, Tetzlaff JE, Sripathirathan K, Carrasco GA, Shankaran M, Van de Kar LD, Muma NA and Battaglia GB (2005). Paroxetine is effective in desensitizing 5-HT_1A receptor function in adult offspring exposed prenatally to cocaine. Psychopharmacology, 180(2):316-326.
• Bailey DJ, Tetzlaff JE, Cook JM, He X and Helmstetter FJ. Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on pavlovian conditioning (2002). Neurobiology of Learning & Memory, 78(1):1-10.
• Serpe CJ, Tetzlaff JE, Coers S, Sanders VM and Jones KJ. Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice (2002). Brain Behavior and Immunity, 16(6):808-812.
• Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D' Souza DN, Tetzlaff JE, Garcia F, Sullivan Hanley NR, Kumar S, Petersen BR, Gray TS, Battaglia G, Muma NA and Van de Kar LD. Evidence that neuroendocrine responses to (-)DOI is mediated by 5-HT_2A receptors in the hypothalamic paraventricular nucleus (2002). The Journal of Neuroscience, 22(21):9635-9642.